HER2-positive breast cancer: What is it? - Mayo Clinic HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2) This protein promotes the growth of cancer cells
Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic El cáncer de mama HER2-positivo es un tipo de cáncer que da un resultado positivo para una proteína llamada receptor 2 del factor de crecimiento epidérmico humano (HER2) Esta proteína fomenta el crecimiento de las células cancerosas En aproximadamente 1 de cada 5 cánceres de mama, las
Invasive lobular carcinoma - Diagnosis and treatment - Mayo Clinic Invasive lobular carcinomas are less likely to make extra HER2, so they're less likely to respond to this treatment Your treatment plan will depend on many factors Your healthcare team considers the stage of the cancer and how quickly it's growing Your care team also considers your overall health and what you prefer Breast cancer surgery
Trastuzumab (intravenous route) - Side effects uses Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and gastroesophageal (stomach and esophagus) cancer Trastuzumab prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein